ARTICLE | Company News
Biopharm, Orquest deal
April 10, 2000 7:00 AM UTC
Orquest and Biopharm will exclusively develop products combining growth factors with bioengineered matrices for spine, fracture, dental and cartilage repair. Biopharm will contribute its MP52 recombin...